| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Aug 21, 2025 | AMG Frontier Small Cap Growth Fund | 13.9% | -2.5% | LTH, ODD, SIMO, STRL | AI Adoption, earnings recovery, infrastructure, innovation, Small Cap Growth | The letter discusses small-cap growth recovery as tariffs ease and earnings visibility improves. Management highlights AI adoption, infrastructure spending, and new product cycles as catalysts for revenue acceleration. The outlook supports selective growth exposure with improving profitability. | SAIA ODD STRL LTH INDI SIMO ATI PGY |
View |
| 2025 Q4 | Feb 5, 2026 | Baron Small Cap Fund | -1.6% | -0.7% | CGNX, CWA, FROG, GWRE, HLI, ICLR, IT, JBT, KNSL, KTOS, MTD, NEPT, NOVT, ODD, PLNT, RBC, RRR, SITE, TDG, VRT | AI, Data centers, defense, growth, Quality, small caps, technology | AI infrastructure buildout drove strong performance in holdings like Vertiv and Legence. JFrog benefited as customers leveraged generative AI to improve developer productivity, driving increased binary creation and platform usage. The manager expects corporations to show continued productivity gains as AI is adopted to reduce costs and open new revenue opportunities. Data center activity was a key driver for several holdings. Vertiv Holdings benefited from robust data center infrastructure demand with 29% organic revenue growth. Legence Corp, an engineering and maintenance services company, was a strong contributor due to robust data center activity. Aerospace and defense players were among the best performers in 2025, including Kratos Defense & Security Solutions, Karman Holdings, and RBC Bearings. The manager notes heightened aerospace and defense spending and improving margins in this sector. The manager expects small-cap companies to grow faster than large caps going forward, which is not typical of recent years. Better growth ahead for small caps could lead to market broadening and leadership change. Small caps have historically grown more slowly than large caps, contributing to extended underperformance. | View | |
| 2025 Q3 | Oct 29, 2025 | Polen Capital – U.S. Small Company Growth | 21.1% | 27.1% | BE, CRS, JOBY, ODD, POWL, TMDX | aerospace, AI Infrastructure, Electrification, energy, innovation | The funds performance was driven by companies benefiting from rapid innovation cycles in clean energy, electrification, AI infrastructure, and next-generation aerospace. Strong contributors included Bloom Energy, Joby Aviation, and Powell Industries, all tied to structural growth in power demand and advanced industrial technologies. The manager emphasizes innovation as the primary long-term driver over macro factors such as rate cycles. | SOFI BE GOOGL TSLA |
View |
| 2025 Q4 | Jan 18, 2026 | Conestoga Mid Cap Composite | -5.8% | -4.7% | AAON, AZTA, BCPC, BLFS, BMI, BSY, BWMN, COCO, CPRT, CSGP, CSW, CWAN, CWST, CYX, DGII, DSGX, ELVA, ESE, FSV, GNRC, GWRE, HEI.A, IDXX, IIIV, IRMD, IT, JKHY, KRMN, LMAT, MAMA, MEG, MLAB, MMSI, NGEN, NOVT, ODD, OLO, PHR, PL, PLMR, POOL, QTWO, RBC, RGEN, ROAD, ROL, ROP, SPSC, SSTI, STVN, TKNO, TREX, TRNS, TYL, UTI, VCEL, VEEV, VERX, VRSK, WCN, WLDN, WSO, WST | AI, Biotech, defense, healthcare, industrials, mid cap, Quality, technology | The manager emphasizes their focus on high-quality stocks with steady earnings characteristics, noting that their portfolio's emphasis on high-quality, steady earners continued to face headwinds in a market focused on short-term macroeconomic shifts. They believe quality stocks will eventually reclaim leadership after periods of low-quality outperformance. Small Cap biotechnology and pharmaceuticals emerged as significant outperformers in Q4, representing 132% of the Russell 2000 Growth Index's total returns. The manager notes they are materially underweight this sector, which created headwinds for relative performance as biotech rallied 33% for the year. The market showed persistent preference for AI-related hardware and infrastructure stocks, with AI themes dominating Index returns. The manager notes that capital flowed into more speculative AI names within the benchmark, creating valuation compression for traditional quality holdings. Defense-related stocks were among the key drivers of benchmark performance, with investors concentrating capital in defense stocks. The manager notes their lack of exposure to defense contractors weighed on relative results as this sector outperformed significantly. | GNRC BSY CSGP VEEV POOL WST IDXX ROL RGEN JKHY |
View |
| 2025 Q4 | Jan 18, 2026 | Conestoga SMid Cap Composite | -2.7% | -4.7% | AAON, AZTA, BCPC, BLFS, BMI, BSY, BWMN, COCO, CPRT, CSGP, CSW, CWAN, CWST, CYX, DGII, DSGX, ELVA, ESE, FSV, GNRC, GWRE, HEI.A, IDXX, IIIV, IRMD, IT, JKHY, KRMN, LMAT, MAMA, MEG, MLAB, MMSI, NGEN, NOVT, ODD, OLO, PHR, PL, PLMR, POOL, QTWO, RBC, RGEN, ROAD, ROL, ROP, SPSC, SSTI, STVN, TKNO, TREX, TRNS, TYL, UTI, VCEL, VEEV, VERX, VRSK, WCN, WLDN, WSO, WST | Biotechnology, defense, growth, industrials, Quality, small caps, technology | Small Caps achieved nearly 9% earnings growth in 2025 and are projected to grow by an additional 32% in 2026, contrasting with 13% growth expected for Large Caps. Small Caps are trading at a nearly 25% discount to Large Caps, creating a compelling case for outperformance for the first time since 2020. The market experienced extreme leadership concentrated in low-quality, high-beta, unprofitable stocks during the April-October rally. However, profitable stocks began outperforming unprofitable counterparts by over 5% from mid-October through year-end, suggesting high-quality stocks may be reclaiming leadership. Small Cap Biotech/Pharmaceutical stocks represented 132% of the Russell 2000 Growth Index's total returns in the fourth quarter alone, after comprising just 11% through the third quarter. The bioprocessing market showed clear signs of recovery with companies delivering encouraging order growth. Defense technology companies specializing in highly engineered, mission-critical systems showed strong performance. Companies with exposure to space, missiles, hypersonic, and defense programs generated mid-teens organic revenue growth complemented by acquisitions. | GNRC KRMN AAON ROAD STVN TREX POOL FSV CWAN CSW JKHY RBC RGEN |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Twitter / X | @BourbonCap | Oddity Tech Ltd. | Household & Personal Products | Personal Care Products | Bull | NASDAQ | BeautyTech, Consumerbrands, DataPlatform, diagnostics, Directtoconsumer, Israel, Personalcare, Teledermatology | View Pitch |
| Feb 4, 2026 | Twitter / X | @weary_centurion | ODDITY Tech Ltd. | Personal Care Products | Personal Care Products | Bull | NASDAQ | Beauty, compounder, Cosmetics, Data, Directtoconsumer, ecommerce, Founderled, Moat, Personalization, RuleOf40, valuation, Wellness | View Pitch |
| Jan 21, 2026 | Fund Letters | David Neiderer | Oddity Tech Ltd. | Consumer Discretionary | Personal Care Products | Bull | NASDAQ | Artificial Intelligence, Beauty Technology, Consumer Data, direct-to-consumer, operating margins | View Pitch |
| Jan 16, 2026 | Value Investors Club | zipper | Oddity Tech Ltd | Consumer Discretionary | Personal Products | Bear | NASDAQ | Consumer-Discretionary, Beauty, Wellness, AI, E-commerce, Personal-Care, Health, Growth. | View Pitch |
| Dec 3, 2025 | Fund Letters | James A.Colgan | Oddity Tech Ltd. | Consumer Staples | Personal Products | Bull | NASDAQ | AI, Beauty, brands, consumer, ecommerce, growth | View Pitch |
| Sep 16, 2025 | Short Thesis | The Bear Cave | Oddity Tech Ltd | Information Technology | Personal Products (Online Beauty) | Bear | NASDAQ | AI, Beauty, CAC, DTC, Marketing | View Pitch |
| Sep 16, 2025 | Short Thesis | NINGI Research | Oddity Tech Ltd | Information Technology | Specialty Retail (E-Commerce Beauty) | Bear | NASDAQ | Beauty, CAC, Competition, e-commerce, Personalization | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||